Latest News about NVS
Recent news which mentions NVS
From MarketWatch
 From Benzinga
 
   Novartis' Sandoz Foresees Rapid Growth Post Spin-Off in Generics Market Amid Upcoming Patent Expirations
   
  June 08, 2023
  Tickers 
   NVS
  
  
  From Benzinga
 From MarketWatch
 From Benzinga
 From Benzinga
 
   Immix Biopharma's Subsidiary Says Investigational CAR T Therapy Shows 100% Response Rate In Amyloidosis
   
  
  
  May 22, 2023
  From Benzinga
 
   Why Is AVROBIO (AVRO) Stock Up 83% Today?
   
  
  
  May 22, 2023
  From InvestorPlace
 From MarketWatch
 From Benzinga
 
   What's Going On With Immix Biopharma Stock Today
   
  
  
  May 03, 2023
  From Benzinga
 From Benzinga
 
   Johnson & Johnson Ignites CAR-T Ambitions With Licensing Pact With Cellular Biomedicine
   
  
  
  May 02, 2023
  From Benzinga
 
   Rare Blood Disorder Treatment Breakthrough: Novartis' Candidate Improves Hemoglobin To Near-Normal Levels
   
  April 26, 2023
  Tickers 
   NVS
  
  
  From Benzinga
 
   After Q1 Review, Novartis Narrows R&D Pipeline To Prioritize High-Value Transformative Medicines
   
  April 25, 2023
  Tickers 
   NVS
  
  
  From Benzinga
 
   3 Top Biotech Stocks Defying the Bear Market
   
  
  
  April 25, 2023
  From Motley Fool
 Tickers 
   NVS
  
  
  From MarketWatch
 From Benzinga
 
   Novartis Says Relapsing Multiple Sclerosis Patients Remained Free From Disease Progression For Up Five Years With Kesimpta Treatment
   
  April 20, 2023
  Tickers 
   NVS
  
  
  From Benzinga
 
   Why Shares of Legend Biotech Jumped Wednesday
   
  
  
  April 19, 2023
  From Motley Fool
 
   New York Rep. Daniel Goldman Bought Over $50K Worth of Novartis Stock: Here's What You Should Know
   
  April 18, 2023
  Tickers 
   NVS
  
  
  From Benzinga
 
   2 Best Biotech Stocks to Buy for the Long Haul
   
  
  
  April 17, 2023
  From Motley Fool
 
   7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
   
  
  
  April 16, 2023
  From InvestorPlace
 
   Relay Therapeutics' Stock Price Premium Vs Peers Is Justified By Its Platform Technology, Analyst Says
   
  
  
  April 13, 2023
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
